+86-755-28171273
Home / Knowledge / Details

Nov 29, 2021

Haier Biological and Stenden robots to create robot-assisted intelligent medical scenes

On November 26, Qingdao Haier Bio-medical Co., LTD. (hereinafter referred to as "Haier Bio") and Stenden Robotics (Shenzhen) Co., LTD. (hereinafter referred to as "Stenden Robotics") signed a strategic cooperation on robot-assisted intelligent Medical Scenarios. In the cooperation, Haier Bio will introduce Stenden robot artificial intelligence technology into its blood component preparation, drug management and other scenes, promote the popularization of robots in the intelligent medical scene, and speed up the digital, unmanned and convenient upgrade of biosafety digital medical solutions for the Internet of Things.



The medical scene will be digitized and upgraded


With the continuous development of digital technology and the acceleration of r&d and application of big data and artificial intelligence technologies, new medical infrastructure is ushering in the "spring" of digital development. The 14th Five-Year Plan and the 2035 Vision also clearly stated that we will comprehensively promote the building of a healthy China and carry out pilot demonstrations in the field of smart medicine.


Accelerating the pace of digital construction and comprehensively improving the level of medical security has become the development consensus of end users in the medical and health fields such as hospitals at all levels and biotechnology enterprises across the country. However, the medical scenario management has the characteristics of high safety requirements, strong time constraints and fine material control, and the traditional management mode often cannot meet the needs. Therefore, the introduction of medical robots with low error, high safety and strong adaptability is gradually becoming an industry trend.


It is understood that Stende robot is the industry's leading industrial mobile robot r & D and production enterprises, but also the 3C industry's largest domestic focus on the development of laser AMR, its products have served 3C, semiconductor, photovoltaic, lithium, medical and pharmaceutical industries and many other customers. But as the world's leading integrated solutions providers of biological safety of Internet of things, haier biological innovation of biological medical scenario, have been used in more than 120 countries and regions, covering in domestic hospital, biological science and technology enterprises, colleges and universities, research institutions, CDC, plasma stations, medical and health fields such as end user testing institutions.


The strategic cooperation between Haier biological and Stende robot will greatly accelerate the digital process of medical scene management in China. At the scene, Wang Yongkun, CEO of Stende Robot, said: "By linking Stende robots into haier's intelligent medical scene, it will bring more secure, accurate and efficient scenarios to the medical field and promote the popularization of robots in the intelligent medical scene." Chen Haitao, Vice General Manager of Haier Bio, said, "Both parties will give full play to their respective technological advantages, accelerate the intelligent, digital and unmanned development process of urban blood management and drug management, and further promote the new digital medical infrastructure while achieving cost reduction and efficiency improvement."




Iot innovation, press the accelerator button for new medical infrastructure


As the application of industrial Internet in the new infrastructure field of biosafety digital medical treatment, Haier Bio builds a full-process and full-scene intelligent scheme with the help of Internet of Things technology, and presses the "new infrastructure" acceleration button in the process of medical digitization and informatization construction to bring about the transformation of digital medical management experience.


For a city, improving the efficiency of emergency blood supply, simplifying the process of clinical blood use and realizing the maximum application value of blood will directly affect the safety of blood use and the guarantee of emergency blood use. With an insight into the industry demand, Haier Biotechnology launched the urban smart blood management program. Through the information-based reconstruction of the urban blood center and the city's blood hospital, the digitalized management of the whole process from blood collection to blood use is realized, so that each bag of blood has a digital business card to record the information of the whole process of each bag of blood. Based on the data of brain city, city wisdom blood management solutions for users to build AI middle of blood, blood analysis middle and middle CaiGongXie data such as solution, and by building a clinical decision support, transfer of blood, blood blood storage management, intelligence collection, such as scene, service city scene, all blood power hospital, blood services and health committee to strengthen clinical use Improve the level of rational blood use in clinical science and promote the reform of blood management system.


Up to now, the digital blood management model has been implemented in more than 100 grade A hospitals, and the construction of the overall urban blood network scheme in Hubei and Shandong provinces is also accelerating.


In fact, comply with the trend of digital medical development and national biological safety strategy, haier biological create wisdom blood network in addition to the innovation, also for vaccine safety, biological samples and lab safety, drug safety and so on to build up the wisdom of the whole scene solutions, based on user requirements in terms of automation, intelligent, integrated upgrade, provide more biological medical customization scenarios, in full Build a biosafety net within the sphere of the ball.


This time, Haier Biological and Stenden robot reached a strategic cooperation, realizing the extension and expansion of their own medical scene services, expanding the influence and competitiveness of the industry. For Haier bio, it is also a necessary link to lead the intelligent transformation of urban blood and medicine management and upgrade the management mode of biosafety scenarios. In the future, Haier Bio will continue to focus on user needs, release the innovation vitality of the Internet of Things science and technology ecology, and lead the transformation and development of the health industry to the digital direction through the iterative upgrading of the Internet of Things biosecurity scene, accelerate the new digital medical infrastructure process, and continue to contribute to the construction of "Healthy China".


Manly Battery which located in Shenzhen,China. A leading Lithium battery manufacturer over 12 years ,widly used for Robostic industry,if there is any project need to evluate ,pls feel free tosend email to info@manlybatteries.com

Send Message